Search / 154 results found Showing: 1-10 of 154
MONDAY, Jan. 17, 2022 (HealthDay News) -- U.S. insurers are paying millions of dollars a year to cover the cost of ivermectin for COVID-19 patients despite a lack of proof the anti-parasitic drug is effective against the virus, a new study finds.
- In a prespecified analysis of all Phase 2/3 study patients with positive PCR at screening, opaganib improved the median time to viral RNA clearance by at least 4 days; Median of 10 days for viral clearance in the opaganib arm vs. clearance median not reached by end of 14-day treatment in placebo arm (Hazard Ratio 1.34; nominal p-value=0.043, N=437/463)
THURSDAY, Jan. 13, 2022 (HealthDay News) -- A drug used to treat several types of cancer is also an effective treatment for aggressive forms of endometrial cancer, the second most common cancer in women worldwide, a new clinical trial shows. The endometrium is the inner lining of the uterus.
WEDNESDAY, Jan. 12, 2022 (HealthDay News) -- People on bone-protecting drugs often take breaks from them for a few years. Now a new study finds that a "holiday" from the medication risedronate (Actonel) may come with a slightly increased risk of hip fracture.
As Omicron surges, how important are COVID case counts anymore? Vaccines have reduced the risks of severe COVID, making it harder to interpret the threat of a COVID surge through case counts alone -- particularly in the face of the Omicron variant, experts say. Read more
TUESDAY, Jan. 11, 2022 (HealthDay News) -- It's a move that could severely limit the number of people taking the controversial new Alzheimer's drug Aduhelm: Medicare on Tuesday proposed to only cover the cost of the pricey medication for people enrolled in approved clinical trials.
TUESDAY, Jan. 11, 2022 (HealthDay News) -- In a medical first, doctors from the University of Maryland have implanted the heart of a genetically modified pig in a 57-year-old man facing the final stages of heart disease. The surgical feat, known as xenotransplantation, opens the door to the possibility that more patients in dire need of heart transplants could get them.
MONDAY, Jan. 10, 2022 (HealthDay News) -- Medicare has been told to reassess a significant premium increase it had announced that largely stemmed from the expensive new Alzheimer disease drug Aduhelm.
MONDAY, Jan. 10, 2022 (HealthDay News) -- Medicare has been told to reassess a significant premium increase it had announced that largely stemmed from the expensive new Alzheimer's drug Aduhelm.